The OCR was markedly reduced in FLT3-ITD+ AML cell lines MOLM13 and MV4–11 upon 24 h TTFA treatment, but not significantly in FLT3-wt cells (Fig. 3b). The gene discussed is FLT3; the disease is acute myeloid leukemia.